Australian researchers say the blood test uses an antibody from immunized mouse cells to follow white blood cells during bone marrow transplants. White blood cells activate when graft versus host disease begins and the antibody alerts doctors at an early stage that donor cells are beginning to attack the patient's cells, allowing earlier treatment.

Related Summaries